Co-Authors
This is a "connection" page, showing publications co-authored by Manuel Rubio-Rivas and Francesc Formiga.
Connection Strength
0.463
-
Risk Categories in COVID-19 Based on Degrees of Inflammation: Data on More Than 17,000 Patients from the Spanish SEMI-COVID-19 Registry. J Clin Med. 2021 May 20; 10(10).
Score: 0.237
-
Beneficial effect of corticosteroids in preventing mortality in patients receiving tocilizumab to treat severe COVID-19 illness. Int J Infect Dis. 2020 Dec; 101:290-297.
Score: 0.227